AstraZeneca smashes forecasts in Q2 after seeing off Pfizer
AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a USD 118 billion takeover approach from rival drugmaker Pfizer two months ago.
Jul 31, 2014, 12:26 PM IST